Drug Research

Bristol Myers Squibb has expanded its ongoing strategic partnership with Schrödinger through a new agreement to deploy the agentic AI co-scientist platform, Bunsen, across its research operations. Building upon an established collaboration in which Bristol Myers Squibb already utilizes...

The pharmaceutical industry is experiencing a significant shift in the development of fast acting oral medications, driven by the need for rapid onset of action and improved patient adherence. The optimization of drug release profiles is fundamental to therapeutic...

The pharmaceutical industry is currently witnessing a significant expansion in the clinical utility of glucagon-like peptide 1 receptor agonists, moving well beyond their initial applications in type 2 diabetes and obesity management. As more data from large-scale cardiovascular and...

The pharmaceutical sector is currently undergoing a significant transition from monotherapy to multi-receptor targeting in the management of metabolic disorders. While single-agent glucagon-like peptide 1 receptor agonists have provided a fundamental foundation for treating type 2 diabetes and obesity,...

The pharmaceutical sector is currently undergoing a fundamental shift as new classes of metabolic agents move through the clinical pipeline. While injectable glucagon-like peptide 1 receptor agonists have set a high bar for efficacy in weight loss and glycemic...

The pharmaceutical industry is currently witnessing a significant shift in how metabolic therapies are conceptualized and developed, specifically through the integration of computational intelligence. The traditional methodology for identifying and validating glucagon-like peptide 1 receptor agonists has historically been...

The development of sustained-release drug delivery systems has transformed the treatment of chronic diseases by allowing for the controlled release of therapeutic agents over extended periods. This approach reduces the frequency of administration, improves patient compliance, and maintains drug...